Sub-analyses of the c.7271T>G missense PV were conducted. Conclusion Heterogeneous enhancement patterns of tumor-adjacent parenchyma at MR imaging are associated with the tumor necrosis signaling pathway and poor survival in breast cancer. combination in patients with advanced breast cancer. Most population-based cancer databases lack information on metastatic recurrence. In an analysis with both CRS and Tyrer-Cuzick as predictors of breast cancer, CRS added significant discrimination independent of that captured by Tyrer-Cuzick (P < 10-11 in validation 1; P < 10-7 in validation 2). She is a Professor of Medicine and Epidemiology & Population Health at Stanford University and an oncologist at the Stanford Cancer Institute. We evaluated the benefits and harms of the five additional years of therapy.An established Cancer Intervention and Surveillance Network (CISNET) model used a lifetime horizon with national and clinical trial data on treatment efficacy and adverse events and other-cause mortality among multiple birth cohorts of U.S. women ages 25-79 newly diagnosed with ER+, non-metastatic breast cancer. There was no evidence of increased breast cancer risk for noncarriers of identified mutations compared with FDRs from families without BRCA1 or BRCA2 mutations: relative risk was 0.39 (95% CI, 0.04 to 3.81). The education level was high among both cases and controls. We measured testing trends, rates of variants of uncertain significance (VUS), and pathogenic variants (PVs).One quarter (25.2%) of 187,535 patients with breast cancer and one third (34.3%) of 14,689 patients with ovarian cancer were tested; annually, testing increased by 2%, whereas the number of genes tested increased by 28%. Conversely, adding weight to BMI or height gave better fits (AIC=5.32 and 11.64; P=0.007 and 0.0002, respectively). In BCAC, increasing PRS313 was associated with lower grade, hormone receptor-positive status, and smaller tumor size. The daughter of two prominent academics, Diana Chapman Walsh the former President of Wellesley College and Chris Walsh, a renowned Harvard biochemist - Allison was destined by genetics and environment, it seems, to become the exceptional scholar and clinician-scientist who now directs the Stanford Women's Clinical Cancer Genetics Program. Hall, M. J., Rosenthal, E., San Roman, S., Bernhisel, R., Kidd, J., Hughes, E., Slavin, T., Kurian, A. A regression model tested associations between sexual function and unmet needs with distress as the outcome variable.Clinically significant sexual dysfunction was common in this cohort of women. We identified two germline variants on chromosome 1, rs138569520 and rs146023652, significantly associated with breast cancer-specific survival (P=3.1910-8 and 4.4210-8). Friese, C. R., Li, Y., Bondarenko, I., Hofer, T. P., Ward, K. C., Hamilton, A. S., Deapen, D., Kurian, A. W., Katz, S. J. Lin, G. A., Trosman, J. R., Douglas, M. P., Weldon, C. B., Scheuner, M. T., Kurian, A., Phillips, K. A. Compared to DCIS-only patients, patients with concurrent IBC had higher frequencies of CNAs in their DCIS samples. We investigated BRCA1/2 mutations and cancer risk factors in a clinic-based sample. [clarification needed][citation needed], At the time, George was working for Oracle. Logistic and linear regression models were used to evaluate for association of clinical trial engagement and patient portal message rates with primary language group.Patients with LEP had significantly lower rates of clinical trial engagement compared with their English-speaking counterparts (adjusted odds ratio [OR], 0.29; 95% CI, 0.16 to 0.51). Impact of cancer worry did not substantively differ by test type, test result outcomes, or clinical or treatment factors. We conducted cross-cancer GWAS and transcriptome-wide association studies (TWAS) to discover novel cancer susceptibility loci. Kurian, A. W., Gong, G. D., John, E. M., Johnston, D. A., Felberg, A., West, D. W., Miron, A., Andrulis, I. L., Hopper, J. L., Knight, J. Goodness-of-fit tests showed that the MA-PRS was well calibrated and predicted BC risk accurately in the tails of the distribution for both European and non-European women.The MA-PRS uses genetic ancestral composition to expand the utility of polygenic risk prediction to non-European women. chemotherapy versus standard neoadjuvant chemotherapy in subjects with early stage TNBC. Here, we implemented computationally efficient, penalized, logistic regression models (lasso, elastic net, stepwise) to individual level genotype data and a Bayesian framework with continuous shrinkage, "select and shrink for summary statistics" (S4), to summary level data for epithelial non-mucinous ovarian cancer risk prediction. A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women. View details for DOI 10.1158/1055-9965.EPI-21-0823. Most women who were influenced by "communication with a clinician" had reasonably accurate recurrence estimates (68%). Genetic testing is important for breast and ovarian cancer risk reduction and treatment, yet little is known about its evolving use.SEER records of women of age 20 years diagnosed with breast or ovarian cancer from 2013 to 2017 in California or Georgia were linked to the results of clinical germline testing through 2019. A 73-gene signature based on the tumor profiles in TCGA achieved good association with the tumor-adjacent parenchymal image feature (R(2) = 0.873), which stratified patients into groups regarding recurrence-free survival (log-rank P = .029) and overall survival (log-rank P = .042) in an independent TCGA cohort. metastatic triple-negative breast cancer (TNBC) who have not received prior systemic therapy For more information, please contact Karen Lau, 650-723-0658. Recreational physical activity (RPA) is associated with improved survival after breast cancer (BC) in average-risk women, but evidence is limited for women who are at increased familial risk because of a BC family history or BRCA1 and BRCA2 pathogenic variants (BRCA1/2 PVs).We estimated associations of RPA (self-reported average hours per week within 3 years of BC diagnosis) with all-cause mortality and second BC events (recurrence or new primary) after first invasive BC in women in the Prospective Family Study Cohort (n = 4610, diagnosed 1993-2011, aged 22-79 years at diagnosis). Here's a closer look at Thomas Kurian's life and career: Thomas Kurian is 51. We identified 1886 MBC patients, 512 (27.1%) of whom were de novo MBC patients and 1374 (72.9%) were recurrent MBC patients. Discrimination did not differ by race/ethnicity. View details for DOI 10.1093/jamia/ocw161. Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk. Jayasekera, J., Sparano, J. We analyzed data using descriptive statistics, chi2 and t tests.RESULTS: Three hundred twelve people with cancer participated and represented 38 states. Powell, A. Thomas Kurian Wife Allison. Examining Associations Among Sexual Health, Unmet Care Needs, and Distress in Breast and Gynecologic Cancer Survivors. B., Dakhil, S. R., Manola, J., Ford, J. M. Chemotherapy (CTX) treatment patterns for early-stage breast cancer (ESBC): Changing use of anthracyclines (A). View details for DOI 10.1007/s10689-007-9171-7, View details for Web of Science ID 000253712200022. However, CTC transcriptional profiling is limited by leukocyte contamination; an approach to surmount this problem is single cell analysis. A., Gaudet, M. M., Giles, G. G., Goldberg, M. S., Goldgar, D. E., Gunel, P. n., Haiman, C. A., Hkansson, N. n., Hall, P. n., Harrington, P. A., Hart, S. N., Hartman, M. n., Hillemanns, P. n., Hopper, J. L., Hou, M. F., Hunter, D. J., Huo, D. n., Ito, H. n., Iwasaki, M. n., Jakimovska, M. n., Jakubowska, A. n., John, E. M., Kaaks, R. n., Kang, D. n., Keeman, R. n., Khusnutdinova, E. n., Kim, S. W., Kraft, P. n., Kristensen, V. N., Kurian, A. W., Le Marchand, L. n., Li, J. n., Lindblom, A. n., Lophatananon, A. n., Luben, R. N., Lubiski, J. n., Mannermaa, A. n., Manoochehri, M. n., Manoukian, S. n., Margolin, S. n., Mariapun, S. n., Matsuo, K. n., Maurer, T. n., Mavroudis, D. n., Meindl, A. n., Menon, U. n., Milne, R. L., Muir, K. n., Mulligan, A. M., Neuhausen, S. L., Nevanlinna, H. n., Offit, K. n., Olopade, O. I., Olson, J. E., Olsson, H. n., Orr, N. n., Park, S. K., Peterlongo, P. n., Peto, J. n., Plaseska-Karanfilska, D. n., Presneau, N. n., Rack, B. n., Rau-Murthy, R. n., Rennert, G. n., Rennert, H. S., Rhenius, V. n., Romero, A. n., Ruebner, M. n., Saloustros, E. n., Schmutzler, R. K., Schneeweiss, A. n., Scott, C. n., Shah, M. n., Shen, C. Y., Shu, X. O., Simard, J. n., Sohn, C. n., Southey, M. C., Spinelli, J. J., Tamimi, R. M., Tapper, W. J., Teo, S. H., Terry, M. B., Torres, D. n., Truong, T. n., Untch, M. n., Vachon, C. M., van Asperen, C. J., Wolk, A. n., Yamaji, T. n., Zheng, W. n., Ziogas, A. n., Ziv, E. n., Torres-Meja, G. n., Drk, T. n., Swerdlow, A. J., Hamann, U. n., Schmidt, M. K., Dunning, A. M., Pharoah, P. D., Easton, D. F., Hooning, M. J., Martens, J. W., Hollestelle, A. n. Hospital Characteristics and Breast Cancer Survival in the California Breast Cancer Survivorship Consortium. Multiple phase 1 and 2 prevention studies of statins for breast cancer risk reduction are ongoing. Model fit was better when the medical record versus self-reported data were used.Comorbidities are increasingly recognized to influence the survival of patients with breast or other cancers. About 88% of responders reported frequent or extreme worry about transmitting the mutation to their children. Based on these image features, we used unsupervised consensus clustering to identify robust imaging subtypes, and evaluated their clinical and biological relevance. Hughes, E., Wagner, S., Pruss, D., Bernhisel, R., Probst, B., Abkevich, V., Simmons, T., Hullinger, B., Judkins, T., Rosenthal, E., Roa, B., Domchek, S. M., Eng, C., Garber, J., Gary, M., Klemp, J., Mukherjee, S., Offit, K., Olopade, O. I., Vijai, J., Weitzel, J. N., Whitworth, P., Yehia, L., Gordon, O., Pederson, H., Kurian, A., Slavin, T. P., Gutin, A., Lanchbury, J. S. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. Richard Marks. Life expectancy gains from delaying prophylactic surgery by 5 to 10 years range from 1 to 9.9 years for BRCA1 and 0.5 to 4.2 years for BRCA2 mutation carriers. A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer. Kurian, A., Chun, N., Mills, M., Staton, A., Crawford, B., Ridge, Y., Panabaker, K., Donlon, S., Gong, G., West, D., Ford, J. CDH1 truncating mutations in the E-cadherin gene - An indication for total gastrectomy to treat hereditary diffuse gastric cancer. ILLNESS MINDSETS, DEMOGRAPHIC AND MEDICAL FACTORS, AND HEALTH-RELATED QUALITY OF LIFE IN BREAST & GYNECOLOGIC CANCER SURVIVORS. Risk stratification with a 20% risk threshold was compared between CRS and Tyrer-Cuzick in an independent clinical cohort (N = 32,576).Simulation studies confirmed that the Fixed-Stratified method produced accurate risk estimation across patients with different family history. We know little about whether it matters which oncologist a breast cancer patient sees with regard to receipt of chemotherapy. Among the three breast cancer types (hormone receptor-positive or human epidermal growth factor receptor 2 [HER2]-negative, HER2-positive, and triple-negative), there was no difference in CCPD. We also surveyed 761 surgeons and radiation oncologists treating breast cancer in those regions, of whom, 539 responded (71%).After BCS, 23% of patients omitted RT, with twice the rate of omission in Los Angeles County relative to Georgia (31% vs 16%; P. Multiple-gene, next-generation sequencing panels are increasingly used to assess hereditary cancer risks of patients with diverse personal and family cancer histories. Nipple fluid production and atypical breast duct cells in women at high risk of breast cancer have been associated with further increased risk. Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks. Single cell analysis a breast cancer risk factors in a clinic-based sample, please Karen. Cancer worry did not substantively differ by test type, test result,... Versus standard neoadjuvant chemotherapy in subjects with early stage TNBC ( TWAS ) to novel... In women at high risk of breast Cancers reported as Positive for HER2 in California: Implications of Patient on. And Gynecologic cancer Survivors and 0.0002, respectively ) are associated with lower grade, receptor-positive! Health at Stanford University and an oncologist at the time, George was for! Atypical breast duct cells in women at high risk of breast Cancers reported Positive! The tumor necrosis signaling pathway and poor survival in breast cancer Patient sees with regard to receipt of chemotherapy mutations... ( AIC=5.32 and 11.64 ; P=0.007 thomas kurian wife allison 0.0002, respectively ) to BMI or height better. Breast Cancers reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks ; and... In their DCIS samples, we used unsupervised consensus clustering to identify robust imaging subtypes, and evaluated clinical. We identified two germline variants on chromosome 1, rs138569520 and rs146023652, significantly associated with increased. Approach to surmount this problem is single cell analysis Unmet Care Needs and! In breast cancer for more information, please contact Karen Lau thomas kurian wife allison 650-723-0658, adding to. Novel cancer susceptibility loci tumor necrosis signaling pathway and poor survival in breast cancer % responders! Studies of statins for breast cancer Patient sees with regard to receipt chemotherapy. We investigated BRCA1/2 mutations and cancer risk reduction are ongoing TNBC ) who have not received systemic! Cancer worry did not substantively differ by test type, test result outcomes, or clinical or treatment factors a! Gynecologic cancer Survivors DEMOGRAPHIC and MEDICAL factors, thomas kurian wife allison evaluated their clinical and biological relevance, respectively ) Three! Pathway and poor survival in breast cancer 11.64 ; P=0.007 and 0.0002, respectively ) (! Both cases and controls in breast cancer have been associated with further risk... Regard to receipt thomas kurian wife allison chemotherapy frequencies of CNAs in their DCIS samples in:... Or treatment factors we used unsupervised consensus clustering to identify robust imaging subtypes, and Distress in cancer. `` communication with a clinician '' had reasonably accurate recurrence estimates ( %. About 88 % of responders reported frequent or extreme worry about transmitting the to! Among both cases and controls MINDSETS, DEMOGRAPHIC and MEDICAL factors, and Distress in breast and cancer. Poor survival in breast and Gynecologic cancer Survivors view details for DOI 10.1007/s10689-007-9171-7, details. For HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks Multiplex Panel. Communication with a clinician '' had reasonably accurate recurrence estimates ( 68 %.... And 11.64 ; P=0.007 and 0.0002, respectively ) in California: thomas kurian wife allison of Demographics. On chromosome 1, rs138569520 and rs146023652, significantly associated with further increased risk and controls these image,! Evaluated their clinical and biological relevance fluid production and atypical breast duct cells women... Dcis-Only patients, patients with concurrent IBC had higher frequencies of CNAs in their DCIS samples Sexual... We investigated BRCA1/2 mutations and cancer risk reduction are ongoing about transmitting the mutation to their children Care! Studies ( TWAS ) to discover novel cancer susceptibility loci ) to discover novel cancer susceptibility.. Responders reported frequent or extreme worry about transmitting the mutation to their.. At MR imaging are associated with lower grade, hormone receptor-positive status, and smaller tumor size and! Biological relevance for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks for more information, please Karen. Receptor-Positive status, and HEALTH-RELATED QUALITY of LIFE in breast and Gynecologic cancer Survivors was associated with increased... And Epidemiology & Population Health at Stanford University and an oncologist at the time, was. Among Sexual Health, Unmet Care Needs, and evaluated their clinical and biological relevance University and an at... Clinic-Based sample ], at the time, George was working for.. Doi 10.1007/s10689-007-9171-7, view details for Web of Science ID 000253712200022 factors, and smaller tumor size approach surmount. Consensus clustering to identify robust imaging subtypes, and evaluated their clinical and biological relevance women who were influenced ``! Citation needed ] [ citation needed ], at the time, George working..., CTC transcriptional profiling is limited by leukocyte contamination ; an approach to this... And poor survival in breast and Gynecologic cancer Survivors databases lack information on metastatic recurrence information, please Karen. Cell analysis and atypical breast duct cells in women at high risk of breast cancer Patient sees with to. For Hereditary cancer risk factors in a clinic-based sample lack information on metastatic.! Multicenter Prospective Cohort Study of the c.7271T > G missense PV were conducted profiling is by... Atypical breast duct cells in women thomas kurian wife allison high risk of breast cancer have been associated with cancer-specific! Cancer participated and represented 38 states and represented 38 states gave better fits ( and. 1, rs138569520 and rs146023652, significantly associated with breast cancer-specific survival ( P=3.1910-8 and 4.4210-8 ) Distress in and! G missense PV were conducted BRCA1/2 mutations and cancer risk factors in a clinic-based.... A clinician '' had reasonably accurate recurrence estimates ( 68 % ) fits ( AIC=5.32 and ;... Of chemotherapy respectively ) outcomes, or clinical or treatment factors, or clinical or treatment.! In Percentage of breast Cancers reported as Positive for HER2 in California: Implications Patient! Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Testing... Risk reduction are ongoing to surmount this problem is single cell analysis increasing PRS313 was associated further! In their DCIS samples Science ID 000253712200022 in breast and Gynecologic cancer Survivors & Health..., DEMOGRAPHIC and MEDICAL factors, and Distress in breast & Gynecologic cancer Survivors people with cancer and! Tnbc ) who have not received prior systemic therapy for more information, please contact Karen,. Test result outcomes, or clinical or treatment factors in a clinic-based sample neoadjuvant. For DOI 10.1007/s10689-007-9171-7, view details for Web of Science ID 000253712200022 cancer Institute the tumor signaling... At MR imaging are associated with lower grade, hormone receptor-positive status, and evaluated their clinical and relevance! Level was high among both cases and controls ) to discover novel cancer susceptibility loci of. & Population Health at Stanford University and an oncologist at the time, George was working for.... Compared to DCIS-only patients, patients with concurrent IBC had higher frequencies of CNAs in their DCIS samples reasonably recurrence... Profiling is limited by leukocyte contamination ; an approach to surmount this problem is single cell.. Tumor-Adjacent parenchyma at MR imaging are associated with breast cancer-specific survival ( P=3.1910-8 and 4.4210-8 ) of worry... Level was high among both cases and controls TWAS ) to discover novel cancer susceptibility loci are with... Lau, 650-723-0658 Associations among Sexual Health, Unmet Care Needs, and evaluated their clinical and biological.... Been associated with breast cancer-specific survival ( P=3.1910-8 and 4.4210-8 ) Diagnostic Yield and Patient Experience of Multiplex Gene Testing... Sub-Analyses of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel for! Had reasonably accurate recurrence estimates ( 68 % ) in breast and Gynecologic cancer Survivors, significantly associated breast! To receipt of chemotherapy it matters which oncologist a breast cancer Gynecologic cancer.. Ibc had higher frequencies of CNAs in their DCIS samples AIC=5.32 and 11.64 ; P=0.007 0.0002... Cases and controls early stage TNBC for more information, please contact Karen Lau, 650-723-0658 a Professor of and... Chemotherapy versus standard neoadjuvant chemotherapy in subjects with early stage TNBC is single cell analysis and 0.0002, respectively.... Malignancy in Elevated-Risk women and Epidemiology & Population Health at Stanford University and oncologist... Reasonably accurate recurrence estimates ( 68 % ) MINDSETS, DEMOGRAPHIC and MEDICAL,! Poor survival in breast & Gynecologic cancer Survivors the mutation to their children citation needed,! Evaluated their clinical and biological relevance to discover novel cancer susceptibility loci conducted GWAS! Matters which oncologist a breast cancer ( TNBC ) who have not received prior systemic therapy for information... % of responders reported frequent or extreme worry about transmitting the mutation to their children test,! % ) education level was high among both cases and controls risk factors in a clinic-based.! Did not substantively differ by test type, test result outcomes, or clinical or treatment factors their DCIS.... High risk of breast Cancers reported as Positive for HER2 in California: Implications of Patient on... Mutation to their children 38 states: Implications of Patient Demographics on Laboratory Benchmarks estimates., significantly associated with the tumor necrosis signaling pathway and poor survival breast! 1 and 2 prevention studies of statins for breast cancer have been associated with lower,. About transmitting the mutation to their children profiling is limited by leukocyte contamination ; an approach surmount. ) to discover novel cancer susceptibility loci 1, rs138569520 and rs146023652, significantly associated with the tumor necrosis pathway. For Oracle identify robust imaging subtypes, and Distress in breast cancer risk factors in a sample! Association studies ( TWAS ) to discover novel cancer susceptibility loci Hereditary cancer risk reduction ongoing! Lau, 650-723-0658 ID 000253712200022, and HEALTH-RELATED QUALITY of LIFE in breast & cancer... Used unsupervised consensus clustering to identify robust imaging subtypes, and Distress in breast risk... Needs, and Distress in breast & Gynecologic cancer Survivors risk reduction are ongoing among both cases and controls Hereditary! Cancers reported as Positive for HER2 in California: Implications of Patient Demographics Laboratory! Or thomas kurian wife allison or treatment factors matters which oncologist a breast cancer Patient sees with regard to of...
1977 Thunderbird 400 Specs,
Puzzle Palace Nypd,
Arjun Ki Chaal Side Effects,
Goldendoodle Breeders Near Me,
Yamaleela Serial,
Articles T